Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the world's leading supplier of tubing-free insulin pump technology with its Omnipod® brand, today announced positive...
The SGLT2 inhibitor dapagliflozin is well tolerated regardless of diabetes status according to new analyzes from the DARE-19 study in adults who were hospitalized...